William Vasquez+FollowWhy Whooping Cough Is Back (Again)Whooping cough is making a comeback in the US, with cases doubling compared to last year. Experts say it’s partly because fewer kids are getting vaccinated and anti-vax attitudes are on the rise. The illness is especially risky for babies, and outbreaks are hitting schools hard. Doctors are worried because herd immunity is slipping—if vaccination rates drop below 95%, everyone’s at higher risk. If you’re due for a booster or expecting a baby, doctors say now’s the time to get protected! #WhoopingCough #Vaccines #PublicHealth #Parenting #HealthNews #Health130Share
nathan87+FollowSlovakia Hits Pause on COVID ShotsSlovakia just put the brakes on buying more COVID vaccines while they double-check safety claims. The PM, who’s always been skeptical about vaccines, says there are concerns about unlisted ingredients and high DNA levels in the shots. This move follows advice from a known vaccine critic, and now the country’s waiting for a science review before spending millions more. Meanwhile, critics are calling this a distraction from bigger political issues. Wild, right? #Slovakia #COVID19 #Vaccines #News #HealthDebate #Health100Share
Caleb Richmond+FollowRSV Shots Now for 50+? Here’s What’s New!Just spotted some big news for anyone 50 and up: CDC advisers say RSV shots should be available for at-risk folks as young as 50 (down from 60+)! That could help so many who worry about catching RSV, which can get pretty serious. Plus, they’re still figuring out the best timing for boosters and looking at more data. Would you get the shot if recommended? Let’s talk! #RSV #HealthUpdate #Vaccines #CDC #StayHealthy #Health60Share
Spencer Brewer+FollowWill New Vaccine Recommendations Roll Out?The CDC’s Advisory Committee is finally meeting to discuss new vaccine recommendations after a long delay. The stakes are high as timely guidance impacts everything from insurance coverage to public health. They’re considering lowering the RSV risk age to 50+, which could save lives and cut healthcare costs by providing earlier protection. But concerningly, flu vaccine votes were removed from the agenda. Let’s hope the committee tackles these critical decisions soon. Delays could mean the difference between widespread protection and leaving high-risk groups vulnerable. #HealthMatters #Vaccines #PublicHealth #CDC #Health60Share
